Patents by Inventor Michael K. Kenrick

Michael K. Kenrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9260711
    Abstract: The present invention to relates to methods and kits which can be used to amplify nucleic acids with the advantage of decreasing user time and possible contamination. The PCR reagents are bound to a solid matrix for easy processing and amplification of DNA samples.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: February 16, 2016
    Assignee: GE HEALTHCARE UK LIMITED
    Inventors: Kathryn L. Lamerton, Cheryl L. Potts, Simon L. Stubbs, Michael K. Kenrick
  • Publication number: 20140154667
    Abstract: The present invention to relates to methods and kits which can be used to amplify nucleic acids with the advantage of decreasing user time and possible contamination. The PCR reagents are bound to a solid matrix for easy processing and amplification of DNA samples.
    Type: Application
    Filed: March 13, 2013
    Publication date: June 5, 2014
    Applicant: GE HEALTHCARE UK LIMITED
    Inventors: KATHRYN L. LAMERTON, CHERYL L. POTTS, SIMON L. STUBBS, MICHAEL K. KENRICK
  • Patent number: 5556598
    Abstract: A device for capturing a component present in a fluid 18 a pipette tip having a rearward end 15 adapted to be fitted on a micro-pipette, and a forward end 12 with a membrane 17, adapted to bind the component, extending across the pipette tip.
    Type: Grant
    Filed: September 13, 1993
    Date of Patent: September 17, 1996
    Assignee: Amersham International plc.
    Inventors: Margaret P. Raybuck, Michael K. Kenrick, David A. Parry
  • Patent number: 5447864
    Abstract: A method of separating cell nuclei from cells comprises: treating a fluid containing whole cells so as to selectively lyse the cytoplasmic membrane together with a small proportion of the nuclear membranes but leaving a large proportion of the cell nuclei intact; applying the treated fluid to a membrane whereby a mesh of DNA from the lysed nuclei is formed on the surface and captures intact cell nuclei. A device for use in the method is described.
    Type: Grant
    Filed: September 14, 1993
    Date of Patent: September 5, 1995
    Assignee: Amersham International Limited
    Inventors: Margaret P. Raybuck, Michael K. Kenrick, David A. Parry, Andrew L. Bertera, John G. Anson, Nicola M. Williamson